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Research brief

FINDINGS
FROM LANDSCAPE
ANALYSIS IN EBONYI ON
PRE-ECLAMPSIA/ECLAMPSIA
Despite global efforts to reduce
preventable maternal and neonatal
mortality, Nigeria’s maternal mortality ratio
is estimated at 576 deaths per 100,000
live births and neonatal death is estimated
at 37 per 1,000 live births 1.
Maternal and newborn deaths due to pre-eclampsia and
eclampsia (PE/E) are preventable, yet in Nigeria this is the most
significant direct cause of maternal deaths.
To appreciate the enormity of this problem at country and state
levels, a landscape analysis was conducted by the Population
Council in 2015 on PE/E in seven states in Nigeria. The main
objectives of the landscape analysis were:

JANUARY 2016

•

To understand the level of programmatic and policy
support for PE/E prevention and treatment;

•

To analyze the gaps in providers’ knowledge and
competence in preventing, detecting, and managing PE/E;

•

To determine primary health care (PHC) facilities’
capacities to manage PE/E;

•

To assess community awareness, beliefs, and experiences
around PE/E;

•

To understand the volume of research on PE/E in the last
15 years; and

•

To determine priority areas for research and programmatic
interventions around PE/E.

The Ending Eclampsia project seeks to expand access
to proven, underutilized interventions and commodities
for the prevention, early detection, and treatment of preeclampsia and eclampsia and strengthen global partnerships.

Made possible by the generous support of the
American people through the United States Agency for
International Development (USAID).

PE/E IN BRIEF
• Pre-eclampsia is a condition
in pregnant women marked by an
increase in blood pressure and
protein in urine after 20 weeks
gestation.
• Providing high quality antenatal care
improves the prevention and early
detection of pre-eclampsia and can
prevent its progression to eclampsia.
• Eclampsia is a life-threatening
condition characterized by
convulsions in women with PE.
• Women in developing countries are
300 times more likely to die from
eclampsia than women in developed
countries.
• Prescribing low-dose aspirin and
calcium to at-risk women can prevent
pre-eclampsia and eclampsia.
• Pre-eclampsia and eclampsia can
be managed by administering antihypertensive drugs and magnesium
sulphate (MgSO4).
• MgSO4 is the safest and most
effective treatment for severe PE/E,
and is one of 13 UN Life-Saving
Commodities for Women and
Children.
• PE/E and other hypertensive
disorders in pregnancy increase the
risk of pre-term births, which can
lead to low birth weight, anemia, and
stunting.
• Improved prevention, increased
detection, and effective treatment
of PE/E can prevent unnecessary
maternal and newborn deaths.

The Population Council conducts research and delivers
solutions that improve lives around the world. Big
ideas supported by evidence: It’s our model for global
change. popcouncil.org
© 2015 The Population Council, Inc.

FACILITY CAPACITY AND
PREPAREDNESS
To assess institutional preparedness, researchers
visited 20 facilities in Ebonyi State and recorded that
two (10%) of the facilities had guidelines available for
management of pre-eclampsia, five (25%) had all ANC
equipment for the detection of PE/E and five (25%) use
MgSO4 for the treatment of eclampsia.

Of concern is the limited capacity to provide cesarean
section, neonatal resuscitation and blood transfusion.
PHCs in Ebonyi also have a mixed picture in their
capacity to provide EmONC with very few providing
MgSO4.

TABLE 1 Signal functions for Emergency
Obstetric and Newborn Care (EmONC)

“It depends on the capacity of
the staff in primary care center
because MgSO4 is not something
anybody can administer… we only
allow MgSO4 to be administered by
midwives and registered nurses.”
—POLICYMAKER, EBONYI
During facility assessments, researchers determined if
the facilities had the key ANC equipment required to
detect pre-eclampsia, to manage severe PE/E, and to
monitor for MgSO4 toxicity (figure 1).

FIGURE 1 Proportion of facilities with the key
equipment to detect PE and manage severe PE/E

PROVIDER KNOWLEDGE AND
SKILLS
Two-thirds and more than three quarters of providers
knew the signs and symptoms of PE and eclampsia
respectively. Only 52%, however, could correctly
identify chronic hypertension and 9% could recall
signs and symptoms of severe pre-eclampsia.
Researchers also assessed health care providers’
knowledge of drugs used for preventing and managing
PE/E as well as calcium gluconate to treat MgSO4
toxicity (figure 2).
Figure 2 shows limited provider knowledge on
prophylactic use of calcium and aspirin for women

FIGURE 2 Provider knowledge on drugs for
prevention and management of PE/E (n=46)
Three (15%) of facility managers reported always using
MgSO4 to treat PE/E, three (15%) said it is sometimes
used, and 14 (70%) reported that it is never used.
When asked how they obtain MgSO4 supplies at the
facility, the Council found that 33% receive it routinely
from central supply, 50% purchase it locally, and 17%
said they procure it elsewhere (such as NGOs).
Although most of the hospitals assessed have capacity
to provide basic signal functions for emergency
obstetric and newborn care (EmONC), Table 1 shows
that few have the capacity to provide parenteral
anticonvulsants (MgSO4) and only one hospital actually
used MgSO4 in the past three months preceding the
survey.
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at risk of PE and which anti-hypertensives (aldomet
or nifedipine) to use for managing high BP during
pregnancy. The Pritchard regimen for MgSO4
administration is considered the ‘gold standard’ for
preventing and treating convulsions in severe PE/E,
but few providers (11%) could accurately describe
the appropriate loading dose of MgSO4 or name the
antidote for MgSO4 toxicity, calcium gluconate (7%).

QUALITY OF CARE
Quality of antenatal care was assessed through
observations of 10 client-provider interactions and 10
client exit interviews.
Clients should receive eight components of quality
antenatal care at each visit, and researchers asked
the 10 clients whether their health provider completed
each component during the consultation (figure 3).

FIGURE 3 Percent of clients who received all
eight components of ANC

COMMUNITY KNOWLEDGE
AND PERCEPTIONS
The study also conducted in-depth interviews (IDIs)
and focus group discussions (FGDs) for qualitative
information from PE/E survivors, community
stakeholders and families affected by PE/E.
During FGDs with married men, participants reported
poverty, lack of funds to take care of life during
pregnancy, husbands’ waywardness, listening to
stories of pregnancy worries, baby not in good position,
self-medication, staying long before conception, and
drinking alcohol as causes of high blood pressure,
swelling, and bleeding in pregnancy. Men’s solutions
to prevent these complications included: encouraging
pregnant women to go for ANC early, identifying the
problem and notifying health workers, government
assistance, avoiding self-medication, and always eating
a balanced diet.
Women also stated that high BP during pregnancy is
caused by ‘over thinking’, age, early marriage, hardship,
maltreatment from husbands, poverty, as well as the
baby is not breathing well, engaging in stress-inducing
activities, caring for husband, business and children, or
seeking a male child. Women also discussed seeking
help for high blood pressure from the hospital or the
herbal homes.

“High blood pressure will make
your legs rise and you will think
whether you will die.”
In addition to the eight essential components of ANC,
questions and tests should be conducted to assess a
woman’s risk of developing PE/E, to detect PE/E, and
inform clients of the signs of impending eclampsia.
During 30% of the observed ANC consultations,
providers performed the necessary checks to detect
women at risk of developing PE. These included history
of high blood pressure (BP) and diabetes, date of last
delivery, client’s parity, age and weight, edema of face,
hands, legs, and ankles. In addition, 50% of providers
observed in Ebonyi measured women’s BP and checked
urine for protein and 30% of the providers advised
the clients on the symptoms of impending eclampsia
(severe headache, blurred vision, and pre-eclampsia
with generalized body swelling).

—FEMALE FGD PARTICIPANT, EBONYI

“They will put charcoal into the pot
with other medicine and a child will
be placed in between, believing this
will cool the sickness.”
—FEMALE FGD PARTICIPANT, EBONYI
Overall, the qualitative findings showed that the
signs and symptoms associated with PE/E are often
attributed to other causes and that community
members often seek care from either hospitals or
herbal homes. Misconceptions, myths, and mistrust
between communities and health providers negatively
influence care-seeking behaviors.
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SURVIVORS EXPERIENCES
Interviews with survivors documented their careseeking pathways, including their PE/E experience, the
availability and accessibility of essential services and
commodities, and the outcomes of the pregnancy for
mother and child. The quotation below describes one
young woman’s experience with PE/E:

“I am 23 years old. I saw my doctor,
he attended to me and prescribed
my routine drugs and there was no
problem. My BP was measured as
well as my urine. During that time, I
suffered from severe headache, no
blurred vision. I had swelling feet but
no convulsion. My husband assisted
me in the household activities so that
I could rest; my mother-in-law was not
around. They helped [me] through
prayer and said it is good to go to
hospital... They [Health providers]
attended to me well. I paid for the
drugs and treatment, and it wasn’t
high, [but] I lost that baby. ”

Regarding quality of ANC, while all women interviewed
said that the provider checked her blood pressure only
40% check for proteinuria. Providers do not check
for women at high risk of developing PE/E nor give
information for danger signs.
There is some knowledge on PE/E and other problems
in pregnancy. Men seem willing to support their wives
and encourage them to go for ANC and seek emergency
care from hospitals. Women describe stress (by over
thinking and hard physical work) as a major contributor
to PE, but seem to seek care at herbal clinics for high
blood pressure.
A multi-pronged approach is required to address the
health system issues and community perceptions
that create barriers to women accessing quality care
during pregnancy and for complications of pregnancy.
Early detection and management of PE/E is critical to
improve maternal and newborn survival in Nigeria.

RECOMMENDATIONS
•

Advocacy for streamlining state procurement and
linking with existing distribution systems in Nigeria;

•

Connect to work on the 13 UN Life-Saving
Commodities for Women and Children: maternal
drugs include MgSO4;

•

Review policy documents, guidelines, treatment
protocols and algorithms to ensure alignment with
global and national policies.

•

Introduce task-shifting policy on MNH policy
implementation plan for management of PE/E.

•

Train all levels of providers on quality ANC: what,
why, who, how, when and where; early detection
of PE and management of severe PE/E (including
anti-hypertensives and MgSO4 loading dose at PHC
level).

•

Community awareness campaigns to encourage
early ANC and health-seeking behavior for
complications.

—PE/E SURVIVOR, EBONYI

DISCUSSION & CONCLUSION
This landscape analysis in Ebonyi identified the gaps
in facilities’ and providers’ capacities for preventing,
detecting, and managing PE/E; assessing community
awareness, beliefs, and experiences of PE/E; and
determined priority areas for research and programs to
improve access to prevention and treatment.
State-level policymakers are aware of some polices but
there are differing opinions on task-shifting to lower
cadres, especially concerning administering MgSO4
loading dose at PHC level.
There is a mixed picture regarding the signal functions
for EmONC. Facilities have shortages of equipment,
drugs, and supplies to detect PE/E and few have MgSO4
and calcium gluconate in stock. Very few hospitals
appear to have the capacity to conduct cesarean
sections or resuscitate newborns.
Provider knowledge is weak on the signs and symptoms
as well as which drugs to use for prevention and
treatment of PE/E.
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